Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/525
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18074/20272 (89%)
Visitors : 4373302      Online Users : 1071
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CNU IR > Pharmacy and Science > Dept. of Pharmacy > CNU Project >  Item 310902800/525
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/525


    Title: 以肺部界面活性劑抑制樹技體轉染巨噬細胞過程中產生之腫瘤壞死因子-α
    Authors: 郭榮華
    Contributors: 藥物科技研究所
    Date: 2006
    Issue Date: 2008-05-19 15:22:43 (UTC+8)
    Publisher: 台南縣:嘉南藥理科技大學藥物科技研究所
    Abstract: The immunomodulation of pro-inflammatory cytokines such as tumor necrosis factor-α(TNF-α) from macrophages, stimulated by plasmid DNA with CpG motifs, is a critical process for the success of gene therapy. These proinflammatory cytokines have been reported to inhibit transgene expression and induce acute toxicity in lipid-based systemic gene delivery systems. However, very little is known about inflammatory toxicity using non-lipid based gene delivery systems such as dendrimers. In the present study, pulmonary surfactant was proposed to modulate TNF-α secretion in cultured RAW 264.7 murine macrophage-like cells activated by pDNA and dendrimer-mediated transfection. We found that pulmonary surfactant suppressed TNF-α release in macrophages activated by plasmid DNA and dendrimer-mediated transfection. Also, the inhibitory effect of pulmonary surfactant followed a dose-dependent manner. Simultaneously, pulmonary surfactant enhanced transfection efficiencies mediated by dendrimers in macrophage cells. The immunologic properties of some of the individual components of naturally or synthetically pulmonary surfactant have also been investigated. 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC), 1,2-Dioleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium Salt) (DOPG), and tyloxapol have minimally inhibitory effects of TNF-α release in macrophages activated by pDNA and dendrimer-mediated transfection. These findings suggest that incorporation of pulmonary surfactant into dendrimer-based gene delivery systems can offer synergistically advantage effects in anti-inflammation and transfection efficiencies.
    Relation: 計畫編號 : CNIP9502
    Appears in Collections:[Dept. of Pharmacy] CNU Project

    Files in This Item:

    File Description SizeFormat
    95CNIP9502.pdf109KbAdobe PDF927View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback